Based on the provided research papers, here are the findings regarding SNP rs11206510:

* The study "Gain of function variants in PCSK9 gene..." found that carriers of the rs11206510 variant had a higher risk of adverse cardiovascular events after myocardial infarction (OR = 1.34, 95% CI: 1.04-1.73, p = 0.02).
* The study "PCSK9 genetic variants, carotid atherosclerosis..." reported that rs11206510 was associated with increased intima-media thickness in the common carotid artery (Î² = 0.03 mm/year, p = 0.03).
* No specific findings regarding rs11206510 were mentioned in the abstracts of the studies "Associations Between Gene Variants...", "Causal relationship between drug target genes...", or "Lipids, Genetics, and the Risk of Type 2 Diabetes...".

Overall, these studies suggest that SNP rs11206510 may be associated with an increased risk of cardiovascular events and carotid atherosclerosis.